Advance ZincTek (ANO) AGM 2026 presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2026 presentation summary
19 Nov, 2026Trading and outlook
First-quarter sunscreen sales were initially down 71%; by end-October, the decline had narrowed to 20%. US shipments remained unaffected by the Import Alert.
H1 FY27 sales revenue is expected to decline 11%–18%, mainly due to weaker Australian sales following MooGoo statements and ABC coverage; stable fixed overheads are expected to weigh on profit.
ANO is recovering lost Q1 revenue and expects further recovery in H2 FY27; a 3-cent capital reduction is planned for 2027.
FY26 total sales were $13.111m versus $11.639m in FY25, up 12.64%.
Costs and marketing
FY26 operating costs included employees of $1.657m versus $1.637m in FY25, up 1.2%; consulting rose 118.33% to $262k and other costs rose 22.26% to $714k.
Jan–Oct 2026 website sessions rose 563% YoY to 93,929 and visitors rose 688% to 89,389; distributor enquiries increased from 4 to 32.
LinkedIn ad spend fell 9% to $121.3k, while website clicks increased 357% to 122,165 and cost per click declined 80% to $0.99.
UV filter developments
4-MBC is prohibited, restricted or not permitted in 126 jurisdictions; Australia retains a 4% limit, while TGA review options include a 0.39% limit, a 3.8% adult face-and-hands limit or a full ban. Interim decision expected in 2027.
Homosalate remains permitted in Australia up to 15%; proposed TGA options include concentration limits, with an interim decision due by end-2026. EU rules cap it at 7.34% in face products; the US limit is 15%.
A presentation highlighted $330.5m pledged for reef water quality and raised concerns about chemical UV-filter monitoring; nine wastewater plants discharge to the Coral Sea and Marine Park, serving 400,000+ people.
Latest events from Advance ZincTek
- Profit and sales grew double digits, with AI boosting efficiency and new battery projects planned.ANO
H2 2026 - FY24 loss of $903,000 due to North American sales drop; cost cuts and new products to aid FY25 recovery.ANO
H2 2024 - Returned to profitability with strong US sales growth and improved operational efficiency.ANO
H2 2025 - Net profit up 21.38% and revenue up 16.5% year-over-year, with continued sales growth expected.ANO
H1 2026 - Sales and profit surged as cost reductions and new product launches drive growth for 2026.ANO
Investor Presentation